Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
about
Antithrombotic drugs in secondary stroke prevention among a community dwelling older populationCholesterol-modifying strategies for Alzheimer's disease.Navigating the gray zones of stroke management for a graying population.Nurses joining family doctors in primary care practices: perceptions of patients with multimorbidity.Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burdenPopulation-based 5-year follow-up study in Taiwan of dementia and risk of stroke.State-level prevalence of cigarette smoking and treatment advice, by disability status, United States, 2004What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.Under-provision of medical care for vascular diseases for people with dementia in primary care: a cross-sectional reviewUse of statins and risk of hospitalization with dementia: a Danish population-based case-control studyManagement of acute ischaemic stroke in patients with dementia.Increasing comorbidity and health services utilization in older adults with prior stroke.Learning and caring in communities of practice: using relationships and collective learning to improve primary care for patients with multimorbidity.Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis.Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study.Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.What causes increased stroke mortality in patients with prestroke dementia?
P2860
Q28196830-B5EE0773-7890-4C34-AC6F-666276F32D7AQ33347051-401AA7BF-CA2D-44F1-8FE5-7A7472910D92Q33928117-87BA2937-BCC2-436E-9AF7-DBEE189CFACCQ34331632-2CA9FA57-2F20-4175-A0DF-DAC2A87A5FA1Q34451824-4DDCCC22-AC4A-4FD0-BEC4-4F99F40A0178Q34692331-C66F54B0-F0A2-4FD3-B24B-F6CC3C31A966Q36176813-EA8F730C-8C75-4B19-8147-8C89BB2640C7Q36472606-0C7B7F00-3103-405A-9F4D-2C25F1CE5E02Q36558204-68E36A04-C1FF-4B1B-82EC-DD76D0E985BBQ36822295-CD1D724C-2790-4596-A13F-FB9101AE0C68Q38763038-FC86DE2B-39CF-41E3-BCD6-A6560AE858BDQ39269754-0E8D8457-8BEB-442F-BC60-465CFFC53478Q39492158-033FAE2C-9650-4DF7-AFC1-CA5D1C35313EQ40400905-0B9D127C-288F-4955-888A-040AEE74D73BQ44201251-7ED02707-09A3-421D-839A-B4E4C85244C5Q47559889-C3962C2E-92B5-4D6C-9DC9-334E1BD29380Q48951841-9C89D82E-9911-44FF-A950-C6D2096D8D11
P2860
Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Treatment for the secondary pr ...... influence of dementia status.
@ast
Treatment for the secondary pr ...... influence of dementia status.
@en
type
label
Treatment for the secondary pr ...... influence of dementia status.
@ast
Treatment for the secondary pr ...... influence of dementia status.
@en
prefLabel
Treatment for the secondary pr ...... influence of dementia status.
@ast
Treatment for the secondary pr ...... influence of dementia status.
@en
P2093
P2860
P1476
Treatment for the secondary pr ...... influence of dementia status.
@en
P2093
P2860
P304
P356
10.1111/J.1532-5415.1999.TB03839.X
P407
P577
1999-07-01T00:00:00Z